Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer

BACKGROUND: Human papillomavirus (HPV)-related head and neck cancer has been associated with an improved prognosis in patients treated with radiotherapy (RT) +/− chemotherapy (CT); however, RT combined with epidermal growth factor receptor (EGFR) inhibitors has not been fully studied in this group o...

Descripción completa

Detalles Bibliográficos
Autores principales: Pajares, Bella, Trigo, Jose M, Toledo, Maria D, Álvarez, Martina, González-Hermoso, Carlos, Rueda, Antonio, Medina, Jose A, Luque, Vanessa de, Jerez, Jose M, Alba, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637564/
https://www.ncbi.nlm.nih.gov/pubmed/23331666
http://dx.doi.org/10.1186/1471-2407-13-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637564/
https://www.ncbi.nlm.nih.gov/pubmed/23331666
http://dx.doi.org/10.1186/1471-2407-13-26

Ejemplares similares